Mostrar el registro sencillo del ítem

dc.contributor.authorMartinez-Banf, Martha
dc.contributor.authorVélez, Jorge I.
dc.contributor.authorMebarak Chams, Moisés R.
dc.contributor.authorArcos-Holzinger, Mauricio
dc.contributor.authorAcosta-López, Johan E.
dc.contributor.authorGarcía, Ricardo
dc.contributor.authorPerea, María Victoria
dc.contributor.authorArcos-Burgos, Mauricio
dc.contributor.authorLadera, Valentina
dc.identifier.citationMartinez-Banfi, M.; Vélez, J.I.; Mebarak Chams, M.R.; Arcos-Holzinger, M.; Acosta-López, J.E.; García, R.; Perea, M.V.; Arcos-Burgos, M.; Ladera, V. Utility of a Short Neuropsychological Protocol for Detecting HIV-Associated Neurocognitive Disorders in Patients with Asymptomatic HIV-1 Infection. Brain Sci. 2021, 11, 1037. https://
dc.description.abstractHuman Immunodeficiency Virus type 1 (HIV-1) infection is a chronic disease that affects ~40 million people worldwide. HIV-associated neurocognitive disorders (HAND) are common in individuals with HIV-1 Infection, and represent a recent public health problem. Here we evaluate the performance of a recently proposed short protocol for detecting HAND by studying 60 individuals with HIV-1-Infection and 60 seronegative controls from a Caribbean community in Barranquilla, Colombia. The short evaluation protocol used significant neuropsychological tests from a previous study of asymptomatic HIV-1 infected patients and a group of seronegative controls. Brief screening instruments, i.e., the Mini-mental State Examination (MMSE) and the International HIV Dementia Scale (IHDS), were also applied. Using machine-learning techniques, we derived predictive models of HAND status, and evaluated their performance with the ROC curves. The proposed short protocol performs exceptionally well yielding sensitivity, specificity, and overall prediction values >90%, and better predictive capacity than that of the MMSE and IHDS. Community-specific cut-off values for HAND diagnosis, based on the MMSE and IHDS, make this protocol suitable for HAND screening in individuals from this Caribbean community. This study shows the effectivity of a recently proposed short protocol to detect HAND in individuals with asymptomatic HIV-1-Infection. The application of community-specific cut-off values for HAND diagnosis in the clinical setting may improve HAND screening accuracy and facilitate patients’ treatment and follow-up. Further studies are needed to assess the performance of this protocol in other Latin American populations.eng
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.sourceBrain scienceseng
dc.sourceVol. 11, No. 8 (2021)
dc.subjectNeurocognitive disordereng
dc.subjectPredictive modelseng
dc.subjectNeuropsychological screeningeng
dc.subjectMachine learningeng
dc.titleUtility of a Short Neuropsychological Protocol for Detecting HIV-Associated Neurocognitive Disorders in Patients with Asymptomatic HIV-1 Infectioneng
dcterms.referencesMoral De La Rubia, J.; Segovia Chavez, M. Discrimination Against Women Infected with Human Immunodeficiency Virus (HIV) By Members of Their Own Family. Psicogente 2015, 18, 89–103.eng
dcterms.referencesONUSIDA. Hoja Informativa—Últimas Estadísticas Sobre el Estado de la Epidemia de Sida. 2019. Available online: https: // (accessed on 30 January 2020).spa
dcterms.referencesMarin-Webb, V.; Jessen, H.; Kopp, U.; Jessen, A.B.; Hahn, K. Validation of the International HIV Dementia Scale as a Screening Tool for HIV-Associated Neurocognitive Disorders in a German-Speaking HIV Outpatient Clinic. PLoS ONE 2016, 11, e0168225.eng
dcterms.referencesHeaton, R.K.; Franklin, D.R.; Ellis, R.J.; McCutchan, J.A.; Letendre, S.L.; Leblanc, S.; Corkran, S.H.; Duarte, N.A.; Clifford, D.B.; Woods, S.P.; et al. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: Differences in rates, nature, and predictors. J. Neurovirol. 2011, 17, 3–16.eng
dcterms.referencesWoods, S.P.; Moore, D.J.; Weber, E.; Grant, I. Cognitive Neuropsychology of HIV-Associated Neurocognitive Disorders. Neuropsychol. Rev. 2009, 19, 152–168.eng
dcterms.referencesEggers, C.; Arendt, G.; Hahn, K.; Husstedt, I.W.; Maschke, M.; Neuen-Jacob, E.; Obermann, M.; Rosenkranz, T.; Schielke, E.; Straube, E.; et al. HIV-1-associated neurocognitive disorder: Epidemiology, pathogenesis, diagnosis, and treatment. J. Neurol. 2017, 264, 1715–1727.eng
dcterms.referencesAntinori, A.; Arendt, G.; Becker, J.T.; Brew, B.; Byrd, D.A.; Cherner, M.; Clifford, D.B.; Cinque, P.; Epstein, L.; Goodkin, K.; et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology 2007, 69.eng
dcterms.referencesJoska, J.A.; Witten, J.; Thomas, K.G.; Robertson, C.; Casson-Crook, M.; Roosa, H.; Creighton, J.; Lyons, J.; McArthur, J.; Sacktor, N.C. A Comparison of Five Brief Screening Tools for HIV-Associated Neurocognitive Disorders in the USA and South Africa. AIDS Behav. 2016, 20, 1621–1631.eng
dcterms.referencesHeaton, R.K.; Clifford, D.B.; Franklin, D.R.; Woods, S.P.; Ake, C.; Vaida, F.; Ellis, R.J.; Letendre, S.L.; Marcotte, T.D.; Atkinson, J.H.; et al. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology 2010, 75, 2087–2096eng
dcterms.referencesOshinaike, O.O.; Akinbami, A.A.; Ojo, O.O.; Ojini, I.F.; Okubadejo, N.; Danesi, A.M. Comparison of the Minimental State Examination Scale and the International HIV Dementia Scale in Assessing Cognitive Function in Nigerian HIV Patients on Antiretroviral Therapy. AIDS Res. Treat. 2012, 2012, 581531.eng
dcterms.referencesKabuba, N.; Menon, J.A.; Franklin, D.R.; Heaton, R.K.; Hestad, K.A. Use of Western Neuropsychological Test Battery in Detecting HIV-Associated Neurocognitive Disorders (HAND) in Zambia. AIDS Behav. 2017, 21, 1717–1727.eng
dcterms.referencesButters, N.; Grant, I.; Haxby, J.; Judd, L.L.; Martin, A.; McClelland, J.; Pequegnat, W.; Schacter, D.; Stover, E. Assessment of Aids-related cognitive changes: Recommendations of the NIMH workshop on neuropsychological assessment approaches. J. Clin. Exp. Neuropsychol. 1990, 12, 963–978.eng
dcterms.referencesMaj, M.; Starace, F.; Sartourius, N. Neuropsychiatric aspects of HIV-1 infection: Data collection instrument for a WHO crosscultural study. Organ 1991, 69, 243–245.eng
dcterms.referencesGrant, I.; Martin, A. Neuropsychology of HIV Infection; Oxford University Press: Oxford, UK, 1994.eng
dcterms.referencesPugh, K.; Riccio, M.; Jadresic, D.; Burgess, A.P.; Baldeweg, T.; Catalan, J.; Lovett, E.; Hawkins, D.A.; Gruzelier, J.; Thompson, C. A longitudinal study of the neuropsychiatric consequences of HIV-1 infection in gay men. II. Psychological and health status at baseline and at 12-month follow-up. Psychol. Med. 1994, 24, 897–904eng
dcterms.referencesArdila-Ardila, A.; Goodkin, K.; Concha-Bartolini, M.; Lecusay-Ruiz, R.; Mellan-Fajardo, S.O.; Suárez-Bustamante, P.; MolinaVásquez, R.; Lee, D.; Chayeb, G.; Wilkie, F.L. HUMANS: A neuropsychological battery for evaluating HIV 1 infected patients. Rev. Neurol. 2003, 36, 756–762.eng
dcterms.referencesDe Almeida, M.; Kamat, R.; Cherner, M.; Umlauf, A.; Ribeiro, C.E.; de Pereira, A.P.; Franklin, D.; Heaton, R.K.; Ellis, R. Improving Detection of HIV-Associated Cognitive Impairment: Comparison of the International HIV Dementia Scale and a Brief Screening Battery. J. Acquir. Immune Defic. Syndr. 2017, 74, 332.eng
dcterms.referencesZipursky, A.R.; Gogolishvili, D.; Rueda, S.; Brunetta, J.; Carvalhal, A.; McCombe, J.A.; Gill, M.J.; Rachlis, A.; Rosenes, R.; Arbess, G.; et al. Evaluation of brief screening tools for neurocognitive impairment in HIV/AIDS: A systematic review of the literature. AIDS 2013, 27, 2385.eng
dcterms.referencesCysique, L.A.; Casaletto, K.B.; Heaton, R.K. Reliably Measuring Cognitive Change in the Era of Chronic HIV Infection and Chronic HIV-Associated Neurocognitive Disorders. In Current Topics in Behavioral Neurosciences; Springer: Berlin/Heidelberg, Germany, 2019; pp. 1–28.eng
dcterms.referencesChan, L.G.; Ho, M.J.; Lin, Y.C.; Ong, Y.; Wong, C.S. Development of a neurocognitive test battery for HIV-associated neurocognitive disorder (HAND) screening: Suggested solutions for resource-limited clinical settings. AIDS Res. Ther. 2019, 16, 9.eng
dcterms.referencesSmail, R.C.; Brew, B.J. HIV-Associated Neurocognitive Disorder. In The Human Hypothalamus: Neuropsychiatric Disorders; Elsevier: Amsterdam, The Netherlands, 2018; Volume 152, pp. 75–97eng
dcterms.referencesPower, C.; Selnes, O.A.; Grim, J.A.; McArthur, J.C. HIV Dementia Scale: A Rapid Screening Test. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 1995, 8, 273–278.eng
dcterms.referencesSacktor, N.C.; Wong, M.; Nakasujja, N.; Skolasky, R.; Selnes, O.A.; Musisi, S.; Robertson, K.; McArthur, J.C.; Ronald, A.; Katabira, E. The International HIV Dementia Scale: A new rapid screening test for HIV dementia. AIDS 2005, 19, 1367–1374.eng
dcterms.referencesAntinori, A.; Arendt, G.; Grant, I.; The Mind Exchange Working Group; Letendre, S.; Muñoz-Moreno, J.A.; Eggers, C.; Brew, B.; Brouillette, M.-J. Assessment, Diagnosis, and Treatment of HIV-Associated Neurocognitive Disorder: A Consensus Report of the Mind Exchange Program. Clin. Infect. Dis. 2013, 56, 1004–1017.eng
dcterms.referencesHaddow, L.J.; Floyd, S.; Copas, A.; Gilson, R.J.C. A Systematic Review of the Screening Accuracy of the HIV Dementia Scale and International HIV Dementia Scale. PLoS ONE 2013, 8, e61826.eng
dcterms.referencesMoore, D.J.; Roediger, M.J.P.; Eberly, L.E.; Blackstone, K.; Hale, B.; Weintrob, A.; Ganesan, A.; Agan, B.K.; Letendre, S.L.; Crum-Cianflone, N.F. Identification of an Abbreviated Test Battery for Detection of HIV-Associated Neurocognitive Impairment in an Early-Managed HIV-Infected Cohort. PLoS ONE 2012, 7, e47310.eng
dcterms.referencesKamminga, J.; Lal, L.; Wright, E.J.; Bloch, M.; Brew, B.J.; Cysique, L.A. Monitoring HIV-Associated Neurocognitive Disorder Using Screenings: A Critical Review Including Guidelines for Clinical and Research Use. Curr. HIV/AIDS Rep. 2017, 14, 83–92.eng
dcterms.referencesPedraza, O.; Mungas, D. Measurement in Cross-Cultural Neuropsychology. Neuropsychol. Rev. 2008, 18, 184–193.eng
dcterms.referencesRobertson, K.; Jiang, H.; Evans, S.R.; Marra, C.M.; Berzins, B.; Hakim, J.; Sacktor, N.; Silva, M.T.; Campbell, T.B.; Nair, A.; et al. International neurocognitive normative study: Neurocognitive comparison data in diverse resource-limited settings: AIDS Clinical Trials Group A5271. J. Neurovirol. 2016, 22, 472–478.eng
dcterms.referencesRobertson, K.; Jiang, H.; Evans, S.R.; Marra, C.M.; Berzins, B.; Hakim, J.; Sacktor, N.; Silva, M.T.; Campbell, T.B.; Nair, A.; et al. International neurocognitive normative study: Neurocognitive comparison data in diverse resource-limited settings: AIDS Clinical Trials Group A5271. J. Neurovirol. 2016, 22, 472–478.eng
dcterms.referencesParsons, T.D.; Rogers, S.; Hall, C.; Robertson, K. Motor based assessment of neurocognitive functioning in resource-limited international settings. J. Clin. Exp. Neuropsychol. 2007, 29, 59–66.eng
dcterms.referencesMcArthur, J.C.; Brew, B. HIV-associated neurocognitive disorders: Is there a hidden epidemic? AIDS 2010, 24, 1367–1370.eng
dcterms.referencesVélez, J.I. Machine Learning based Psychology: Advocating for A Data-Driven Approach. Int. J. Psychol. Res. 2021, 14, 6–11.eng
dcterms.referencesHenriquez, M.L.C.; Acosta-Lopez, J.; Martínez-Banfi, M.L.; Vélez, J.I.; Mejia-Segura, E.; Lozano-Gutiérrez, S.G.; Sánchez-Rojas, M.; Zurbarán, M.A.; Zurek, E.E.; Arcos-Burgos, M.; et al. ADHD Endophenotypes in Caribbean Families. J. Atten. Disord. 2018.eng
dcterms.referencesValcour, V.; Pohl, K. Machine Learning to Distinguish HAND from Alzheimer’s Disease in HIV over Age 60. 2020. Available online: (accessed on 4 February 2020).eng
dcterms.referencesPluta, A.; Wolak, T.; Soba ´nska, M.; Gawron, N.; Egbert, A.R.; Szyma ´nska, B.; Horban, A.; Firl ˛ag-Burkacka, E.; Bie ´nkowski, P.; Sienkiewicz-Jarosz, H.; et al. HIV and age underlie specific patterns of brain abnormalities and cognitive changes in high functioning patients. Neuropsychology 2019, 33, 358–369.eng
dcterms.referencesBandera, A.; Taramasso, L.; Bozzi, G.; Muscatello, A.; Robinson, J.A.; Burdo, T.H.; Gori, A. HIV-Associated Neurocognitive Impairment in the Modern ART Era: Are We Close to Discovering Reliable Biomarkers in the Setting of Virological Suppression? Front. Aging Neurosci. 2019, 11, 187.eng
dcterms.referencesCysique, L.; Murray, J.; Dunbar, M.; Jeyakumar, V.; Brew, B.; Cysique, L.; Murray, J. A screening algorithm for HIV-associated neurocognitive disorders. HIV Med. 2010, 11, 642–649.eng
dcterms.referencesBreiman, L.; Friedman, J.H.; Olshen, R.A.; Stone, C.J. Classification and Regression Trees; Wadsworth International Group: Belmont, CA, USA, 1984.eng
dcterms.referencesMartínez-Banfi, M.; Vélez, J.I.; Perea, M.V.; García, R.G.; Puentes-Rozo, P.J.; Chams, M.M.; Ladera, V. Neuropsychological performance in patients with asymptomatic HIV-1 infection. AIDS Care Psychol. Socio-Med. Asp. AIDS/HIV 2018, 30, 623–633.eng
dcterms.referencesBetancur, J.; Correa, A.; Estrada; Santiago, E.; Orozco, B.; Velez, H.; Rojas, W.; Borrero, J.; Restrepo, J. Infección Respiratoria en Pacientes con VIH/Sida. En Manual de VIH/SIDA y Otras Infecciones de Transmisión Sexual; Corporación para Investigaciones Biológicas: Medellín, Colombia, 2007spa
dcterms.referencesBecker, J.T.; Kingsley, L.A.; Molsberry, S.; Reynolds, S.; Aronow, A.; Levine, A.J.; Martin, E.; Miller, E.N.; Munro, C.A.; Ragin, A.; et al. Cohort Profile: Recruitment cohorts in the neuropsychological substudy of the Multicenter AIDS Cohort Study. Int. J. Epidemiol. 2015, 44, 1506–1516.eng
dcterms.referencesFolstein, M.F.; Folstein, S.E.; McHugh, P.R. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975, 12, 189–198.eng
dcterms.referencesMungas, D. In-office mental status testing: A practical guide. Geriatrics 1991, 46, 63–66.eng
dcterms.referencesFolstein, M.F.; Folstein, S.E.; McHugh, P.R. Examen Cognoscitivo Minimental; Adaptación Española; TEA: Madrid, Spain, 2002.eng
dcterms.referencesGrant, I. The Neurocognitive Complications of HIV Infection. In Encyclopedia of the Human Brain; Ramachandran, V.S., Ed.; Elsevier: Amsterdam, The Netherlands, 2002; pp. 475–489.eng
dcterms.referencesWeschler, D. Escala de Memoria de Weschler-III; Pearson: Madrid, Spain,
dcterms.referencesRey, A. L’Examen Clinique en Psychologie (The Clinical Psychological Examination); Presse Universitaires de France, Scientific Research Publishing: Paris, France, 1964. Available online: referencespapers.aspx?referenceid=1656248 (accessed on 2 June 2021).eng
dcterms.referencesSchmidt, M. Rey Auditory and Verbal Learning Test: A Handbook; Western Psychological Services: Los Angeles, CA, USA, 1996.eng
dcterms.referencesSpreen, O.; Strauss, E. A Compendium of Neuropsychological Tests, 2nd ed.; Oxford University Press: New York, NY, USA, 1998.eng
dcterms.referencesWeschler, D. Manual de Aplicación y Corrección de la Escala de Inteligencia de Weschler (WAIS-III); Pearson: Madrid, Spain,
dcterms.referencesKaplan, E.; Goddglass, H.; Weintraub, S. Boston Naming Test, 2nd ed.; Pro-Ed: Austin, TX, USA, 2001.eng
dcterms.referencesOstrosky-Solis, F.; Ardila, A.; Rosselli, M. Evaluación Neuropsicológica Breve en Español (Neuropsi) [Brief Neuropsychological Evaluation in Spanish (Neuropsi)]; Pearson: Mexico City, Mexico, 1999.eng
dcterms.referencesRey, A. Test de Copia y de Reproducción de Memoria de Figuras Geométricas Complejas [Test of Copying and Reproduction of Memory of Complex Geometric Figures], 8th ed.; Lea & Febiger: Madrid, Spain, 2003.eng
dcterms.referencesGolden, C.J. Test de Colores y Palabras STROOP [STROOP Test of Colors and Words], 4th ed.; TEA Ediciones: Madrid, Spain, 2005.eng
dcterms.referencesSpielberger, C.D.; Díaz-Guerrero, R. IDARE. Inventario de Ansiedad: Rasgo-Estado. Manual e Instructivo [Trait-State Anxiety Inventory. Manual and Instruction]; Manual Moderno: Mexico City, Mexico,
dcterms.referencesR Core Team. R: A Language and Environment for Statistical Computing; R Foundation for Statistical Computing: Vienna, Austria, 2018. Available online: (accessed on 30 July 2021).eng
dcterms.referencesTherneau, B.T.; Atkinson, B.R. Recursive Partitioning and Regression Trees (R Package R Part Version 4.1-15). 2019. Available online: (accessed on 27 May 2020).eng
dcterms.referencesRao, D.C. CAT scans, PET scans, and genomic scans. Genet. Epidemiol. 1998, 15, 1–18.eng
dcterms.referencesMetz, C.E. Basic principles of ROC analysis. Semin. Nucl. Med. 1978, 8, 238–239.eng
dcterms.referencesBrin, S.; Motwani, R.; Ullman, J.D.; Tsur, S. Dynamic itemset counting and implication rules for market basket data. ACM SIGMOD Rec. 1997, 26, 255–264.eng
dcterms.referencesMcNicholas, P.; Murphy, T.B.; O’Regan, M. Standardising the lift of an association rule. Comput. Stat. Data Anal. 2008, 52, 4712–4721.eng
dcterms.referencesMoore, R.C.; Paolillo, E.W.; Heaton, A.; Fazeli, P.L.; Jeste, D.V.; Moore, D.J. Clinical utility of the UCSD Performance-Based Skills Assessment—Brief (UPSA-B) in adults living with HIV: Associations with neuropsychological impairment and patient-reported everyday functioning difficulties. PLoS ONE 2017, 12, e0183614.eng
dcterms.referencesGoodkin, K.; Hardy, D.J.; Singh, D.; Lopez, E. Diagnostic Utility of the International HIV Dementia Scale for HIV-Associated Neurocognitive Impairment and Disorder in South Africa. J. Neuropsychiatry Clin. Neurosci. 2014, 26, 352–358.eng
dcterms.referencesHaddow, L.J.; Laverick, R.; Daskalopoulou, M.; McDonnell, J.; Lampe, F.; Gilson, R.; Speakman, A.; Antinori, A.; Balestra, P.; Bruun, T.; et al. Multicenter European Prevalence Study of Neurocognitive Impairment and Associated Factors in HIV Positive Patients. AIDS Behav. 2017, 22, 1573–1583.eng
dcterms.referencesHaynes, B.I.; Pitkanen, M.; Kulasegaram, R.; Casey, S.J.; Schutte, M.; Towgood, K.; Peters, B.; Barker, G.; Kopelman, M.D. HIV: Ageing, cognition and neuroimaging at 4-year follow-up. HIV Med. 2018, 19, 376–385.eng
dcterms.referencesIpser, J.C.; Brown, G.G.; Bischoff-Grethe, A.; Connolly, C.; Ellis, R.; Heaton, R.K.; Grant, I.; Translational Methamphetamine AIDS Research Center (TMARC) Group. HIV Infection Is Associated with Attenuated Frontostriatal Intrinsic Connectivity: A Preliminary Study. J. Int. Neuropsychol. Soc. 2015, 21, 203–213.eng
dcterms.referencesKamat, R.; Doyle, K.L.; Iudicello, J.E.; Morgan, E.E.; Morris, S.; Smith, D.; Little, S.J.; Grant, I.; Woods, S.P. Neurobehavioral Disturbances During Acute and Early HIV Infection. Cogn. Behav. Neurol. 2016, 29, 1–10.eng
dcterms.referencesNabha, L.; Duong, L.; Timpone, J. HIV-associated neurocognitive disorders: Perspective on management strategies. Drugs 2013, 73, 893–905.eng
dcterms.referencesMehta, S.R.; Pérez-Santiago, J.; Hulgan, T.; Day, T.R.C.; Barnholtz-Sloan, J.; Gittleman, H.; Letendre, S.; Ellis, R.; Heaton, R.; Patton, S.; et al. Cerebrospinal fluid cell-free mitochondrial DNA is associated with HIV replication, iron transport, and mild HIV-associated neurocognitive impairment. J. Neuroinflamm. 2017, 14, 72.eng
dcterms.referencesGurgel Fernandes Távora, L.; Martins Figueiredo, T.; Moitas Krammer de Mesquita, R.; Ricarte Bezerra, F.; Pinheiro Aquino, B.; de Baima Colares, J.K. HIV and Dementia: Prevalence and Risk Factors (HIV e Demência: Prevalência e Fatores de Risco VIH y Demencia: Prevalencia y Factores de Riesgo). Rev. Bras. Promoção Saúde 2016, 29, 212–218.eng
dcterms.referencesArango-Lasprilla, J.C.; Rogers, H.; Lengenfelder, J.; DeLuca, J.; Moreno, S.; Lopera, F. Cortical and subcortical diseases: Do true neuropsychological differences exist? Arch. Clin. Neuropsychol. 2006, 21, 29–40.eng
dcterms.referencesDwyer, R.; Wenhui, L.; Cysique, L.; Brew, B.; Lal, L.; Bain, P.; Wesselingh, S.; Wright, E. Symptoms of depression and rates of neurocognitive impairment in HIV positive patients in Beijing, China. J. Affect. Disord. 2014, 162, 89–95.eng
dcterms.referencesMaruff, P.; Thomas, E.; Cysique, L.; Brew, B.; Collie, A.; Snyder, P.; Pietrzak, R.H. Validity of the CogState Brief Battery: Relationship to Standardized Tests and Sensitivity to Cognitive Impairment in Mild Traumatic Brain Injury, Schizophrenia, and AIDS Dementia Complex. Arch. Clin. Neuropsychol. 2009, 24, 165–178.eng
dcterms.referencesLopardo, G.D.; Bissio, E.; Iannella, M.D.C.; Crespo, A.D.; Garone, D.B.; Cassetti, L.I. Good Neurocognitive Performance Measured by the International HIV Dementia Scale in Early HIV-1 Infection. J. Acquir. Immune Defic. Syndr. 2009, 52, 488–492.eng
dcterms.referencesAbusamra, V.; Abusamra, L.; Sampedro, B.; Difalcis, M.; Martínez, G.; Dávolos, J.M.; Ferreres, A. Trastornos cognitivos en pacientes VIH-1: La dimensión pragmática de la comunicación verbal. Rev. Neuropsicol. Latinoam. 2014, 6, 22–30.eng
dcterms.referencesBloch, M.; Kamminga, J.; Jayewardene, A.; Bailey, M.; Carberry, A.; Vincent, T.; Quan, D.; Maruff, P.; Brew, B.; Cysique, L. A Screening Strategy for HIV-Associated Neurocognitive Disorders That Accurately Identifies Patients Requiring Neurological Review. Clin. Infect. Dis. 2016, 63, 687–693.eng
dcterms.referencesRobbins, R.N.; Joska, J.; Thomas, K.G.F.; Stein, D.; Linda, T.; Mellins, C.A.; Remien, R.H. Exploring the Utility of the Montreal Cognitive Assessment to Detect HIV-Associated Neurocognitive Disorder: The Challenge and Need for Culturally Valid Screening Tests in South Africa. Clin. Neuropsychol. 2013, 27, 437–454.eng
dcterms.referencesAmusan, P.; Power, C.; Gill, M.J.; Gomez, D.; Johnson, E.; Rubin, L.H.; Fujiwara, E. Lifetime antiretroviral exposure and neurocognitive impairment in HIV. J. Neurovirol. 2020, 26, 743–753.eng
dcterms.referencesNightingale, S.; Winston, A.; Letendre, S.; Michael, B.; McArthur, J.C.; Khoo, S.; Solomon, T. Controversies in HIV-associated neurocognitive disorders. Lancet Neurol. 2014, 13, 1139–1151.eng
dcterms.referencesTedaldi, E.M.; Minniti, N.L.; Fischer, T. HIV-Associated Neurocognitive Disorders: The Relationship of HIV Infection with Physical and Social Comorbidities. BioMed Res. Int. 2015, 2015, 641913.eng
dcterms.referencesFogel, G.B.; Lamers, S.L.; Levine, A.J.; Valdes-Sueiras, M.; McGrath, M.S.; Shapshak, P.; Singer, E.J. Factors related to HIVassociated neurocognitive impairment differ with age. J. Neurovirol. 2014, 21, 56–65.eng
dcterms.referencesJia, P.; Zhao, Z.; Hulgan, T.; Bush, W.; Samuels, D.; Bloss, C.; Heaton, R.K.; Ellis, R.; Schork, N.; Marra, C.M.; et al. Genome-wide association study of HIV-associated neurocognitive disorder (HAND): A CHARTER group study. Am. J. Med. Genet. Part B Neuropsychiatr. Genet. 2017, 174, 413–426.eng
dcterms.referencesMcDonnell, J.; Haddow, L.; Daskalopoulou, M.; Lampe, F.; Speakman, A.; Gilson, R.; Phillips, A.; Sherr, L.; Wayal, S.; Harrison, J.; et al. Minimal Cognitive Impairment in UK HIV-Positive Men Who Have Sex with Men: Effect of Case Definitions and Comparison with the General Population and HIV-Negative Men for the Cognitive Impairment in People with HIV in the European Region (CIPHER) Study Group. J. Acquir. Immune Defic. Syndr. 2014, 67, 120–127.eng
dcterms.referencesSacktor, N.; Robertson, K. Evolving clinical phenotypes in HIV-associated neurocognitive disorders. Curr. Opin. HIV AIDS 2014, 9, 517–520.eng
dcterms.referencesFocà, E.; Magro, P.; Motta, D.; Compostella, S.; Casari, S.; Bonito, A.; Brianese, N.; Ferraresi, A.; Rodari, P.; Pezzoli, M.C.; et al. Screening for Neurocognitive Impairment in HIV-Infected Individuals at First Contact after HIV Diagnosis: The Experience of a Large Clinical Center in Northern Italy. Int. J. Mol. Sci. 2016, 17, 434.eng
dcterms.referencesSanmarti, M.; Ibáñez, L.; Huertas, S.; Badenes, D.; Dalmau, D.; Slevin, M.; Krupinski, J.; Popa-Wagner, A.; Jaen, A. HIV-associated neurocognitive disorders. J. Mol. Psychiatry 2014, 2, 2.eng
dcterms.referencesGarcía-Torres, A.; Vergara-Moragues, E.; Piñón-Blanco, A.; Pérez-García, M. Alteraciones neuropsicológicas en pacientes con VIH e historia previa de consumo de sustancias. Un estudio preliminar. Rev. Latinoam. Psicol. 2015, 47, 213–221.eng
dcterms.referencesNichols, M.J.; Gates, T.M.; Soares, J.R.; Moffat, K.J.; Rae, C.; Brew, B.J.; Cysique, L.A. Atrophic brain signatures of mild forms of neurocognitive impairment in virally suppressed HIV infection. AIDS 2019, 33, 55–66.eng
dcterms.referencesChalermchai, T.; Valcour, V.; Sithinamsuwan, P.; Pinyakorn, S.; Clifford, D.; Paul, R.H.; Tipsuk, S.; Fletcher, J.L.K.; DeGruttola, V.; Ratto-Kim, S.; et al. Trail Making Test A improves performance characteristics of the International HIV Dementia Scale to identify symptomatic HAND. J. Neurovirol. 2013, 19, 137–143.eng
dcterms.referencesSkinner, S.; Adewale, A.; DeBlock, L.; Gill, M.J.; Power, C. Neurocognitive screening tools in HIV/AIDS: Comparative performance among patients exposed to antiretroviral therapy. HIV Med. 2009, 10, 246–252.eng
dcterms.referencesDe Souza, E.M.; Buoniconti, C.S.; Valim, F.; Moura, A.S. Risk factors for neurocognitive impairment in HIV-infected patients and comparison of different screening tools. Dement. Neuropsychol. 2016, 10, 42–46.eng
dcterms.referencesArentoft, A.; Byrd, D.; Robbins, R.N.; Monzones, J.; Miranda, C.; Rosario, A.; Coulehan, K.; Fuentes, A.; Germano, K.K.; D’Aquila, E.; et al. Multidimensional effects of acculturation on English-language neuropsychological test performance among HIV+ Caribbean Latinas/os. J. Clin. Exp. Neuropsychol. 2012, 34, 814–825.eng
dcterms.referencesAlford, K.; Banerjee, S.; Nixon, E.; O’Brien, C.; Pounds, O.; Butler, A.; Elphick, C.; Henshaw, P.; Anderson, S.; Vera, J.H. Assessment and Management of HIV-Associated Cognitive Impairment: Experience from a Multidisciplinary Memory Service for People Living with HIV. Brain Sci. 2019, 9, 37.eng
dcterms.referencesClifford, D.B.; Ances, B.M. HIV-Associated Neurocognitive Disorder (HAND). Lancet Infect. Dis. 2013, 13, 976–986.eng
dcterms.referencesCroucher, A.; Winston, A. Neurological complications of HIV. Medicine 2013, 41, 450–455.eng
dcterms.referencesBarragan Duarte, J.L. Mapa Genético de los Colombianos. Unimedios. 2007. Available online: http://historico.unperiodico.unal. (accessed on 20 April 2021).eng
dcterms.referencesCysique, L.A.; Heaton, R.K.; Kamminga, J.; Lane, T.; Gates, T.M.; Moore, D.M.; Hubner, E.; Carr, A.; Brew, B. HIV-associated neurocognitive disorder in Australia: A case of a high-functioning and optimally treated cohort and implications for international neuroHIV research. J. Neurovirol. 2014, 20, 258–268.eng
dcterms.referencesMebarak, M.; De Castro, A.; Salamanca, M.P.; Quintero, M.F. Salud mental: Un abordaje desde la perspectiva actual de la psicología de la salud. Psicol. desde el Caribe 2009, 23, 83–112spa
dcterms.referencesMarquine, M.J.; Heaton, A.; Johnson, N.; Rivera-Mindt, M.; Cherner, M.; Bloss, C.; Hulgan, T.; Umlauf, A.; Moore, D.J.; Fazeli, P.; et al. Differences in Neurocognitive Impairment among HIV-Infected Latinos in the United States. J. Int. Neuropsychol. Soc. 2018, 24, 163–175.eng
dcterms.referencesSaylor, D.; Dickens, A.; Sacktor, N.; Haughey, N.; Slusher, B.; Pletnikov, M.; Mankowski, J.L.; Brown, A.; Volsky, D.J.; McArthur, D.S.; et al. HIV-associated neurocognitive disorder—Pathogenesis and prospects for treatment. Nat. Rev. Neurol. 2016, 12, 234–248.eng
dcterms.referencesParry, S.; Zetler, S.; Kentridge, A.; Petrak, J.; Barber, T.; Kentridge, A. Simple screening for neurocognitive impairment in routine HIV outpatient care: Is it deliverable? AIDS Care 2017, 29, 1275–1279.eng
dc.type.spaArtículo científicospa

Ficheros en el ítem


Este ítem aparece en la(s) siguiente(s) colección(ones)

  • Artículos
    Artículos científicos evaluados por pares

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial-NoDerivatives 4.0 Internacional